This HTML5 document contains 65 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1086/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q58204816
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel наукова стаття, опублікована у квітні 2003 im April 2003 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 2003
p:P577
wds:Q58204816-3F3A6DCF-2D04-4BD4-A9DF-7F1815EB4A42
wdt:P577
2003-04-15T00:00:00Z
p:P407
wds:Q58204816-BD5D4BED-D29A-472A-A76A-026DDA7B3394
wdt:P407
wd:Q1860
p:P2093
wds:Q58204816-C5EF85FA-1F32-4B78-8D71-585BA3DA1547 wds:Q58204816-D18DB5CB-DC25-4991-A4F6-237EDA0580A6 wds:Q58204816-3F860726-661E-4F23-8E8B-60C504F73DD2 wds:Q58204816-1A1B9E80-7D78-46B8-BCE9-0DEC4884FC7D wds:Q58204816-192ECF30-565D-4F0B-A49D-7CE149315A2A wds:Q58204816-141DC434-D57D-4103-A902-B4C471231CE7 wds:Q58204816-B71BD4AC-3D3E-4865-9184-8F940600A53F wds:Q58204816-7941B2FA-41D7-44FE-A366-495750DE9EFC wds:Q58204816-9177AEF5-A3B2-48DB-9FCE-FFB20DB7E695 wds:Q58204816-4EFEDA91-D322-48CC-A8DE-D01F6B918400 wds:Q58204816-49E0F556-75B8-44A9-8A94-321F63588E47
wdt:P2093
Jose Lacruz Rodrigo Fernando Laguna Pere Domingo Rafael Rubio J. Mallolas Veronica de Miguel Francisco J. Rodriguez‐Arrondo Fernando Dronda Julio Arrizabalaga Josu Baraia‐Etxaburu Pilar Miralles
rdfs:label
Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy
skos:prefLabel
Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy
schema:name
Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy
p:P50
wds:Q58204816-C56598F9-6DDB-4F5B-BC68-B1CA408FFD3F wds:Q58204816-19AAADB5-DAED-4387-B95E-90ACF6CA34EA wds:Q58204816-0086BD80-3F7F-42EC-9580-7F19AE2B290A
wdt:P50
wd:Q42430889 wd:Q47548434 wd:Q57008013
p:P1476
wds:Q58204816-D7AAC32E-417A-4EEE-BCA0-B3354F085D1C
wdt:P1476
Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy
p:P304
wds:Q58204816-EBBD2E31-0C87-437A-BAB8-A245850C82F0
wdt:P304
1047-1052
p:P31
wds:Q58204816-4D303B36-2BFE-4D4A-9ADE-99C8C4C4DCC7
wdt:P31
wd:Q13442814
p:P921
wds:Q58204816-D1E85F78-2660-41A3-BA22-639D330A2DBD wds:Q58204816-4D5D04F7-CE54-4E05-A516-DB331F2A5A3B
wdt:P921
wd:Q704930 wd:Q181600
p:P698
wds:Q58204816-BC809690-9065-42D2-AD8A-18AF2AB43EF0
wdtn:P698
n8:12684918
wdt:P698
12684918
p:P1433
wds:Q58204816-11839256-FCD8-436C-BA91-9C8C7BCFE3D0
wdt:P1433
wd:Q5133764
p:P433
wds:Q58204816-DB7937FF-A862-41E2-82A1-7EC801416B8B
p:P478
wds:Q58204816-34B2F868-EFE0-40A7-9D3A-24D16B1D689E
wdt:P433
8
wdt:P478
36
p:P356
wds:Q58204816-EB79FF9F-4872-420D-8DCB-ECFB88C34D89
wdtn:P356
n12:374048
wdt:P356
10.1086/374048